Clinical Trial Update: Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi's sarcoma has completed. The results provide data on e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma | Phase 2 | Status: COMPLETED